FeedKind® Pet Protein Proven Safe, Digestible, and Gut-Friendly in Long-Term Study Calysta’s cultured protein shows strong results in peer-reviewed research, paving the way for sustainable innovation in pet food the global leader in large-scale cultured protein production, has announced peer-reviewed…
Broken String Biosciences and BioLizard Join Forces to Build AI Platform for Safer Gene Editing New SafeGuide AI tool aims to reduce trial-and-error in gene editing and lower development costs for next-generation therapies Broken String Biosciences, a pioneer in genomic…
TandemAI and Perpetual Medicines Merge to Advance AI and Physics-Driven Drug Discovery Newly combined company will broaden capabilities in small molecule and peptide therapeutics with expanded leadership and integrated technology platforms In a strategic move that strengthens innovation at the…
Renasant Bio Launches with $54.5M to Advance Next-Generation Therapies for ADPKD Renasant Bio (Renasant) today announced its official launch with a bold mission: to pioneer next-generation, disease-modifying treatments for autosomal dominant polycystic kidney disease (ADPKD)—the most common inherited cause of…
Feinstein Institutes Study Focused Ultrasound to Regulate Blood Sugar After Surgery Researchers and clinicians at Northwell Health’s Feinstein Institutes for Medical Research are breaking new ground in the field of bioelectronic medicine, exploring the use of focused ultrasound (FUS) to…
NTT and Tohoku University Pioneer Quantum Leap with Single-Photon Coherent Ising Machines NTT Research and Tohoku University have jointly achieved a significant scientific milestone, pushing the boundaries of quantum computing by developing a highly energy-efficient and powerful form of Coherent…
European Students Excel in Global Cambridge Science Competition Three student teams from across Europe have been honored with awards in the prestigious 2025 Cambridge Science Competition, an international initiative hosted by the International Education division at Cambridge University Press &…
NYB.AI and Pnaseer Form Strategic Alliance to Advance AI-Powered Hair Regeneration Research NYB.AI, a pioneer in AI-driven drug discovery, and Pnaseer Inc., a leader in bio-nanoparticle drug delivery technologies, have announced a strategic partnership to accelerate the discovery and development…
Agenus’ BOT/BAL Combo Delivers 42% Two-Year Survival in MSS Colorectal Cancer: Phase 3 Trial Aligned with FDA Agenus Inc., a pioneer in immuno-oncology, announced compelling new clinical results and regulatory progress for its combination therapy of botensilimab and balstilimab (BOT/BAL).…
Blue Lake and CyanVac Publish Phase 1 Data for Intranasal COVID-19 Vaccine Candidate Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company, and its affiliate CyanVac LLC have announced the publication of the full Phase 1 clinical study data for…
Allurion Submits Final PMA Module to FDA Following Strong AUDACITY Study Results Allurion Technologies, Inc., a global leader in innovative, non-surgical weight loss solutions, announced it has officially submitted the final module of its Pre-Market Approval (PMA) application to the…
Miach Orthopaedics Completes Enrollment in BEAR MOON ACL Study Miach Orthopaedics, Inc., a medical device company revolutionizing anterior cruciate ligament (ACL) treatment, announced that patient enrollment is now complete for its pivotal BEAR MOON study. This major clinical trial compares…